ShareValue scores for 002932.SHE: Valuation 52, Quality 33, Growth 28, Health 44.

002932.SHE
SZSE

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

CN¥14.77(-0.74%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 16%
Valuation
52
Fair Value
Price vs Value
Quality
33
Weak
Business Strength
Growth
28
Weak
Revenue & Earnings
Health
44
Moderate
Financial Stability
Momentum
27
Bearish
Price Trend

Company Details

About

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services, as well as nutrition and health products for immune, gut, reproductive, and sleep health management. It also provides information software and supporting hardware products. In addition, the company offers blood gas and chemistry analyzers, fluorescence immunoassay analyzers, molecular diagnosis kit, coagulation analysis machine, and automated glycohemoglobin detection machine. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026